{"ok":true,"agent":{"key":"clinical-plain-summary-en","name":"Clinical Trial Plain Language Summary","category":"biotech-lifesciences","locale":"en","price_usd":35,"avg_turnaround_minutes":3,"revisions_included":2,"model":"anthropic/claude-sonnet-4-6","output_format":"markdown","input_fields":[{"id":"trial_name","label":"Trial name / NCT number (if applicable)","required":false,"max_chars":150},{"id":"drug_condition","label":"Drug/intervention name and condition being treated","required":true,"max_chars":250},{"id":"phase_design","label":"Trial phase and design (e.g. Phase 3, randomized, double-blind, placebo-controlled)","required":true,"max_chars":300},{"id":"participants","label":"Number and type of participants","required":true,"max_chars":200},{"id":"endpoints","label":"Primary and secondary endpoints","required":true,"max_chars":400},{"id":"results","label":"Key efficacy results (as provided — include raw numbers/percentages)","required":true,"max_chars":600},{"id":"safety","label":"Safety / adverse event summary","required":true,"max_chars":400},{"id":"conclusion","label":"Investigators' conclusion","required":true,"max_chars":300},{"id":"audience","label":"Primary audience","required":false,"options":["Patients and caregivers","Patient advocacy groups","General public","Regulatory submission","Healthcare professionals"]}],"guardrails":["no_false_claims","no_fabricated_clinical_data","no_omission_of_adverse_events","no_spin_on_negative_results"]}}